These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31009010)

  • 41. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.
    Schmitz Y; Lee CJ; Schmauss C; Gonon F; Sulzer D
    J Neurosci; 2001 Aug; 21(16):5916-24. PubMed ID: 11487614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine release mediated by the dopamine transporter, facts and consequences.
    Leviel V
    J Neurochem; 2011 Aug; 118(4):475-89. PubMed ID: 21644994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of prenatal cocaine exposure on amphetamine-induced dopamine release in the caudate nucleus of the adult rabbit.
    Du W; Aloyo VJ; Pazdelski PS; Harvey JA
    Brain Res; 1999 Jul; 836(1-2):194-8. PubMed ID: 10415418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Individual variation in incentive salience attribution and accumbens dopamine transporter expression and function.
    Singer BF; Guptaroy B; Austin CJ; Wohl I; Lovic V; Seiler JL; Vaughan RA; Gnegy ME; Robinson TE; Aragona BJ
    Eur J Neurosci; 2016 Mar; 43(5):662-70. PubMed ID: 26613374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine neuronal transport kinetics and effects of amphetamine.
    Jones SR; Joseph JD; Barak LS; Caron MG; Wightman RM
    J Neurochem; 1999 Dec; 73(6):2406-14. PubMed ID: 10582600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amphetamine activates calcium channels through dopamine transporter-mediated depolarization.
    Cameron KN; Solis E; Ruchala I; De Felice LJ; Eltit JM
    Cell Calcium; 2015 Nov; 58(5):457-66. PubMed ID: 26162812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution.
    Garcia BG; Wei Y; Moron JA; Lin RZ; Javitch JA; Galli A
    Mol Pharmacol; 2005 Jul; 68(1):102-9. PubMed ID: 15795321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Caenorhabditis elegans model to study dopamine transporter deficiency syndrome.
    Illiano P; Lanzo A; Leo D; Paglione M; Zampi G; Gainetdinov RR; Di Schiavi E
    Eur J Neurosci; 2017 Jan; 45(1):207-214. PubMed ID: 27519790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extracellular dopamine and alterations on dopamine transporter are related to reserpine toxicity in Caenorhabditis elegans.
    Reckziegel P; Chen P; Caito S; Gubert P; Soares FA; Fachinetto R; Aschner M
    Arch Toxicol; 2016 Mar; 90(3):633-45. PubMed ID: 25579234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine plays a critical role in the olfactory adaptive learning pathway in Caenorhabditis elegans.
    Raj V; Thekkuveettil A
    J Neurosci Res; 2022 Nov; 100(11):2028-2043. PubMed ID: 35906758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux.
    Wang Q; Bubula N; Brown J; Wang Y; Kondev V; Vezina P
    Neurosci Lett; 2016 May; 622():78-82. PubMed ID: 27113203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.
    Khoshbouei H; Sen N; Guptaroy B; Johnson L'; Lund D; Gnegy ME; Galli A; Javitch JA
    PLoS Biol; 2004 Mar; 2(3):E78. PubMed ID: 15024426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine transporters depolarize neurons by a channel mechanism.
    Carvelli L; McDonald PW; Blakely RD; DeFelice LJ
    Proc Natl Acad Sci U S A; 2004 Nov; 101(45):16046-51. PubMed ID: 15520385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DAT versus D2 receptor binding in the rat striatum: l-DOPA-induced motor activity is better predicted by reuptake than release of dopamine.
    Nikolaus S; Beu M; Angelica De Souza Silva M; Huston JP; Hautzel H; Antke C; Müller HW
    Synapse; 2016 Sep; 70(9):369-77. PubMed ID: 27164322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans.
    Chase DL; Pepper JS; Koelle MR
    Nat Neurosci; 2004 Oct; 7(10):1096-103. PubMed ID: 15378064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism.
    Wei Y; Williams JM; Dipace C; Sung U; Javitch JA; Galli A; Saunders C
    Mol Pharmacol; 2007 Mar; 71(3):835-42. PubMed ID: 17164407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. G protein βγ subunits play a critical role in the actions of amphetamine.
    Mauna JC; Harris SS; Pino JA; Edwards CM; DeChellis-Marks MR; Bassi CD; Garcia-Olivares J; Amara SG; Guajardo FG; Sotomayor-Zarate R; Terminel M; Castañeda E; Vergara M; Baust T; Thiels E; Torres GE
    Transl Psychiatry; 2019 Feb; 9(1):81. PubMed ID: 30745563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA.
    Marvanova M; Nichols CD
    J Mol Neurosci; 2007; 31(2):127-37. PubMed ID: 17478886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition.
    Rizzo FR; Federici M; Mercuri NB
    Neuroscience; 2018 May; 377():69-76. PubMed ID: 29510210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of dopamine receptor in the actions of non-psychoactive phytocannabinoids.
    Shrader SH; Tong YG; Duff MB; Freedman JH; Song ZH
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1366-1370. PubMed ID: 33097185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.